↓ Skip to main content

Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer

Overview of attention for article published in Breast Cancer Research, January 2020
Altmetric Badge

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
15 Mendeley